BPM31510

AssetAlso called coenzyme q10, BPM31510 Nanosuspension Injection, BPM31510 Oral Nanosuspension 4%, Nanoquinone

Supports mitochondrial electron transport and antioxidant defenses.

Stage
Phase 3
Modality
Supplement
Target
Not known
21
Indications
103
Trials
7
Developers

2 trials are still running. Development reported on Nov 9, 2026. bpgbio.com

Indications

21

18 more

In the full profile

  • Target and mechanism1
  • Owner and partners7
  • Trials103
  • Evidence for its targets1
  • Competitors12
  • Aging relevance2
  • Signals7

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets